Deutsche Bank Maintains ROCHE HOLDINGS AG(RHHVF.US) With Sell Rating, Raises Target Price to $302
Express News | Reported Sunday, Roche's Genentech Phase III Study Finds Xolair More Effective And Safer Than Oral Immunotherapy For Food Allergies
J.P. Morgan Maintains ROCHE HOLDINGS AG(RHHVF.US) With Sell Rating, Maintains Target Price $256.72
Deutsche Bank Maintains ROCHE HOLDINGS AG(RHHVF.US) With Sell Rating, Maintains Target Price $295.79
UBS Maintains ROCHE HOLDINGS AG(RHHVF.US) With Buy Rating, Raises Target Price to $376.44
Deutsche Bank Maintains ROCHE HOLDINGS AG(RHHVF.US) With Sell Rating, Raises Target Price to $294.52
Bernstein Maintains ROCHE HOLDINGS AG(RHHVF.US) With Buy Rating, Raises Target Price to $383.43
UBS Upgrades ROCHE HOLDINGS AG(RHHVF.US) to Buy Rating, Announces Target Price $374.27
Morgan Stanley Initiates ROCHE HOLDINGS AG(RHHVF.US) With Hold Rating, Announces Target Price $333.98
Goldman Sachs Maintains ROCHE HOLDINGS AG(RHHVF.US) With Sell Rating, Cuts Target Price to $300.68
Bernstein Maintains ROCHE HOLDINGS AG(RHHVF.US) With Buy Rating, Raises Target Price to $379.16
Goldman Sachs Maintains ROCHE HOLDINGS AG(RHHVF.US) With Sell Rating, Raises Target Price to $300.83
Deutsche Bank Maintains ROCHE HOLDINGS AG(RHHVF.US) With Sell Rating, Raises Target Price to $290.95
J.P. Morgan Maintains ROCHE HOLDINGS AG(RHHVF.US) With Sell Rating, Cuts Target Price to $252.25
Barclays Maintains ROCHE HOLDINGS AG(RHHVF.US) With Hold Rating, Raises Target Price to $318.4
Deutsche Bank Maintains ROCHE HOLDINGS AG(RHHVF.US) With Sell Rating, Cuts Target Price to $274.48
A Quick Look at Today's Ratings for ROCHE HOLDINGS AG(RHHVF.US), With a Forecast Between $252.81 to $373.72
ROCHE HOLDINGS AG To Go Ex-Dividend On March 27th, 2025 With 9.96772 USD Dividend Per Share
Roche Holding AG (RHHBY) Q4 2024 Earnings Call Transcript Summary
Goldman Sachs Maintains ROCHE HOLDINGS AG(RHHVF.US) With Sell Rating, Raises Target Price to $296.69
Unlock the Full List